Stanniocalcin2 acts as an anorectic factor through activation of STAT3 pathway

Yang Jiao; Jiejie Zhao; Guojun Shi; Xing Liu; Xuelian Xiong; Xiaoying Li; Huijie Zhang; Qinyun Ma; Yan Lu

doi:10.18632/oncotarget.19412

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Stanniocalcin2 acts as an anorectic factor through activation of STAT3 pathway

Yang Jiao, Jiejie Zhao, Guojun Shi, Xing Liu, Xuelian Xiong, Xiaoying Li, Huijie Zhang, Qinyun Ma _ and Yan Lu

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:91067-91075. https://doi.org/10.18632/oncotarget.19412

Metrics: PDF 1935 views | HTML 2365 views | ?

Abstract

Yang Jiao1,*, Jiejie Zhao1,*, Guojun Shi1,*, Xing Liu2, Xuelian Xiong2, Xiaoying Li1,2, Huijie Zhang3, Qinyun Ma1 and Yan Lu1,2

1Department of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrinology and Metabolism, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

2Department of Endocrinology, Fudan Institute for Metabolic Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China

3Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China

*These authors contributed equally to this work

Correspondence to:

Qinyun Ma, email: [email protected]

Yan Lu, email: [email protected]

Keywords: appetite, body weight, stanniocalcin 2, STAT3

Received: January 26, 2017 Accepted: July 12, 2017 Published: July 20, 2017

ABSTRACT

The regulation of food intake and body weight has been hotly investigated. In the present study, we show that stanniocalcin2 (STC2), a cytokine ubiquitously expressed and especially upregulated in many types of human cancers, has a regulatory role in food intake and weight loss. Systemic treatment of C57BL/6 mice with recombinant STC2 protein resulted in decreased food intake and body weight, whereas energy expenditure was not affected. Similarly, STC2 treatment also induced anorexia in hyperphagic leptin-deficient mice, leading to a significant reduction in body weight and improvement of blood glucose levels. Furthermore, intracerebroventricular administration of STC2 to mice led to an acute decrease in food intake, which was mediated, at least in part, by activation of STAT3 pathway. Taken together, our results revealed the importance of STC2 in the regulation of feeding behavior as well as body weight.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19412

Publication Alerts

Research Papers:

Stanniocalcin2 acts as an anorectic factor through activation of STAT3 pathway

Abstract